Emmes Group is a global contract research organization advancing health innovation through a network of specialized brands. With deep roots in public-sector research and a growing presence in the biopharma industry, we integrate scientific rigor, operational excellence, and technology-driven solutions to accelerate the development of safe, effective treatments.
Our brands reflect this mission—each contributing focused capabilities that, together, enable full-service support across therapeutic areas, geographies, and trial phases. From AI-powered platforms to global vaccine trials and specialized certification services, our collective strength delivers results that matter.
Our Mission
We bring people, science, and technology together to collaborate
with our customers and deliver global health impact.
Advancing research with scientific excellence and global reach.
Emmes is a full-service specialty CRO with decades of experience designing and managing complex trials across ophthalmology, neuroscience, oncology, rare diseases, cell and gene therapy, and vaccines. With a strong foundation in biostatistics, data management, and clinical operations, Emmes partners with government, non-profit, and biopharma clients to generate meaningful insights that improve health outcomes worldwide.
Transforming data into truth.
Veridix brings AI and advanced analytics to the heart of clinical research. Its purpose-built eClinical platform and AI-driven agents automate key processes—from protocol development and study build to data cleaning and final analysis. By combining data science and clinical expertise, Veridix empowers teams to reduce timelines, increase quality, and uncover deeper insights from their trial data.
Delivering on the promise of vaccines.
VaxTrials is Emmes Group’s dedicated unit focused exclusively on vaccine and infectious disease research for biopharma, biotech, foundations, and non-profits. Built to support global vaccine trials with speed and agility, VaxTrials combines a proven track record in project and site management with Emmes’ full-service CRO capabilities and global reach. We deliver complex, large-scale trials across all phases and geographies with the scientific rigor, flexibility, and quality needed to accelerate your program.
Raising the standard for visual function assessment.
OptymEdge is the global leader in certifying visual acuity examiners and testing environments for clinical trials. Supporting research in ophthalmology, as well as neuroscience and gene therapy, OptymEdge ensures high-quality, consistent visual function data. Its digitized certification platform and global network of certified sites provide sponsors with scalable, reliable solutions for trials worldwide.
Powering public health innovation through data.
Essex Management delivers informatics, data systems, and IT services that support some of the world’s most advanced biomedical research programs. As a long-standing partner to the National Cancer Institute (NCI) and other NIH institutes, Essex helps build and manage the digital infrastructure required for translational research, large-scale data initiatives, and precision medicine efforts that drive public health forward.